King's College London

Funding Information: RJBD is supported by (1) NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London (2) Health Data Research UK, which is funded by the UK Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council, Department of Health and Social Care (England), Chief Scientist Office of the Scottish Government Health and Social Care Directorates, Health and Social Care Research and Development Division (Welsh Government), Public Health Agency (Northern Ireland), British Heart Foundation and Wellcome Trust; (3) the BigData@Heart Consortium, which funded by the Innovative Medicines Initiative-2 Joint Undertaking (grant 116074), which receives support from the European Union Horizon 2020 research and innovation program and European Federation of Pharmaceutical Industries and Associations; (4) the NIHR University College London Hospitals Biomedical Research Centre; (5) the UK Research and Innovation London Medical Imaging & Artificial Intelligence Centre for Value Based Health care; and (6) the NIHR Applied Research Collaboration South London at King’s College Hospital NHS Foundation Trust. Funding Information: This study was funded in part by the National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre at South London and Maudsley NHS (National Health Service) Foundation Trust and King’s College London. Funding Information: We thank all the members of the RADAR-CNS patient advisory board for their contribution to the device selection procedures, and their invaluable advice throughout the study protocol design. We acknowledge that this research was reviewed by the Feasibility and Acceptability Support Team for Researchers (National Institute for Health Research Maudsley Biomedical Research Centre, King’s College London and South London and Maudsley NHS Foundation Trust). Funding Information: RB is funded in part by the King’s College London Medical Research Council Skills Development Fellowship (grant MR/R016372/1), which is funded by the UK Medical Research Council (grant IS-BRC-1215-20018) for the NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London. Funding Information: The Remote Assessment of Disease and Relapse–Major Depressive Disorder project is a component of the Remote Assessment of Disease and Relapse–Central Nervous System (RADAR-CNS) project, which has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (grant 115902), which receives support from European Union Horizon 2020 and the European Federation of Pharmaceutical Industries and Associations. The study was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice, adhering to principles outlined in the National Health Service Research Governance Framework for Health and Social Care (2nd edition). Publisher Copyright: © 2022 JMIR Publications Inc.. All right reserved.